Additionally, B -lines enabled significant patient riskreclassification (continuous NRI 65%, p = 0.03) on top of usual riskstratification (i.e., NYHA and BNP), thus suggesting a relevant improvement inrisk assessment at discharge following HF hospitalisation [22]. The gene discussed is NPPB; the disease is hydrops fetalis.